Pharsight

Keryx Biopharms patents expiration

1. Auryxia patents expiration

AURYXIA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US9328133 KERYX BIOPHARMS Ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(3 months ago)

US7767851 KERYX BIOPHARMS Ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(3 months ago)

US9757416 KERYX BIOPHARMS Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(3 months ago)

US8338642 KERYX BIOPHARMS Ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(3 months ago)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5753706 KERYX BIOPHARMS Methods for treating renal failure
Feb, 2022

(2 years ago)

US8754257 KERYX BIOPHARMS Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(3 months ago)

US8299298 KERYX BIOPHARMS Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
Feb, 2024

(3 months ago)

US8754258 KERYX BIOPHARMS Ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(3 months ago)

US9050316 KERYX BIOPHARMS Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(3 months ago)

US8846976 KERYX BIOPHARMS Ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(3 months ago)

US8901349 KERYX BIOPHARMS Ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(3 months ago)

US8609896 KERYX BIOPHARMS Ferric organic compounds, uses thereof and methods of making same
Feb, 2024

(3 months ago)

US8093423 KERYX BIOPHARMS Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
Apr, 2026

(1 year, 10 months from now)

US10300039 KERYX BIOPHARMS Ferric citrate dosage forms
Jul, 2030

(6 years from now)

US9387191 KERYX BIOPHARMS Ferric citrate dosage forms
Jul, 2030

(6 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Indication(I-790) Nov 06, 2020

Drugs and Companies using FERRIC CITRATE ingredient

Market Authorisation Date: 05 September, 2014

Treatment: Control of serum phosphorous levels; Control of serum phosphorus levels

Dosage: TABLET;ORAL

More Information on Dosage

AURYXIA family patents

Family Patents